In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): Inhibition of Δ9-tetrahydrocannabinol-induced responses and apparent agonist activity

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 2, 1996, Pages 586-594

  Compton, David R ^a,c   Aceto, Mario D ^a   Lowe, John ^b   Martin, Billy R ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID RECEPTOR ANTAGONIST; DRONABINOL; HALOPERIDOL; MORPHINE; RIMONABANT;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; HYPOTHERMIA; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LATENT PERIOD; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; TAIL FLICK TEST;

ANALGESIA; ANIMALS; BODY TEMPERATURE; MALE; MICE; MICE, INBRED ICR; MOTOR ACTIVITY; PIPERIDINES; PYRAZOLES; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; TETRAHYDROCANNABINOL;

EID: 0030423694     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. 9-tetrahydrocannabinol. J. Pharmacol. Exp. Ther. 241: 521-526, 1987.
2. BORNHEIM, L. M., KIM, K., CHEN, B. AND CORREIA, M. A.: Effect of cannabidiol on mouse hepatic microsomal cytochrome p450-dependent anandamide metabolism. Biochem. Biophys Res. Commun. 197: 740-746, 1993.
3. 9-THC: Mechanistic studies. J. Clin. Pharmacol. 21: 227s-234s, 1981.
4. 1-tetrahydrocannabinol reduces its cataleptic effect in mice. Experientia 43: 402-403, 1987.
5. 9-tetrahydrocannabinol. J. Pharmacol. Exp. Ther. 263: 1118-1126, 1992a.
6. COMPTON, D. R., JOHNSON, M. R., MELVIN, L. S. AND MARTIN, B. R.: Pharmacological profile of a series of bicyclic cannabinoid analogs: Classification as cannabimimetic agents. J. Pharmacol. Exp. Ther. 260: 201-209, 1992b.
7. 8-tetrahydrocannabinol. J. Med. Chem. 33: 1437-1443, 1990.
8. 8-tetrahydrocannabinol. Eur. J. Med. Chem. 24: 293-298, 1989.
9. COMPTON, D. R. AND MARTIN, B. R.: Pharmacological evaluation of water soluble cannabinoids and related analogs. Life Sci. 46: 1575-1585, 1990.
10. 9,11-tetrahydrocannabinol. J. Med. Chem. 34: 3310-3316, 1991.
11. COMPTON, D. R., RICE, K. C., DE COSTA, B. R., RAZDAN, R. K., MELVIN, L. S., JOHNSON, M. R. AND MARTIN, B. R.: Cannabinoid structure-activity relationships: Correlation of receptor binding and in vivo activities. J. Pharmacol. Exp. Ther. 265: 218-226, 1993.
12. DELEAN, A., MUNSON, P. AND RODBARD, D.: Simultaneous analysis of families of sigmoidal curves: Application to bioassay, radioligand assay, and physiological dose-response curves. Am. J. Physiol. 235: E97-E102, 1977.
13. DEUTSCH, D. G. AND CHIN, S. A.: Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem. Pharmacol. 46: 791-796, 1993.
14. DEVANE, W. AND AXELROD, J.. Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor by brain membranes. Proc. Natl Acad Sci. USA 91: 6698-6701, 1994.
15. DEVANE, W. A., DYSARZ, F. A., JOHNSON, M. R., MELVIN, L. S. AND HOWLETT, A. C.: Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 34: 605-613, 1988.
16. DEVANE, W. A., HANUS, L., BREUER, A., PERTWEE, R. G., STEVENSON, L. A., GRIFFIN, G., GIBSON, D., MANDELBAUM, A., ETINGER, A. AND MECHOULAM, R.: Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258: 1946-1949, 1992.
17. DI MARZO, V., FONTANA, A , CADAS, H., SCHINELLI, S., CIMINO, G., SCHWARTZ, J. C. AND PIOMELLI, D.: Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372: 686-691, 1994.
18. EVANS, D., LAKE, J. T., JOHNSON, M. R. AND HOWLETT, A.: Endogenous cannabinoid receptor binding activity released from rat brain slices by depolarization. J Pharmacol. Exp. Ther. 268: 1271-1277, 1994.
19. 9-THC-indueed long-lasting muricide. Psychopharmacology (Berl.) 68: 7-13, 1980.
20. GAONI, Y. AND MECHOULAM, R.: Isolation, structure, and partial synthesis of an active constituent of hashish. J. Am. Chem. Soc. 86: 1646-1647, 1964.
21. 9-THC. II. Cannabinol and cannabidiol. Clin. Pharmacol. Ther. 18: 80-83, 1975.
22. HOWLETT, A C., JOHNSON, M. R., MELVIN, L. S. AND MILNE, G. M.: Nonclassical cannabinoid analgetics inhibit adenylate cyclase: Development of a cannabinoid receptor model. Mol. Pharmacol. 33: 297-302, 1988.
23. 9-tetrahydrocannabinol in man. Eur. J. Pharmacol. 28: 172-177, 1974.
24. KRUSZKA, K. AND GROSS, R.: The ATP-and CoA-independent synthesis of arachidonylethanolamide. J. Biol. Chem. 269: 14345-14348, 1994.
25. KUDRIN, A. N. AND DAVYDOVA, O. N.: Elimination of hashish intoxication with phenitrone in dogs. Farmakol Tociskol. 31: 549-552, 1968.
26. LAINTON, J. A. H., HUFFMAN, J. W., MARTIN, B R. AND COMPTON, D. R.: 1-Alkyl-3-(1-naphthoyl)pyrroles: A new cannabinoid class. Tetrahedron Letters 36: 1401-1404, 1995.
27. 9-tetrahydrocannabinol in the rat. Drug Alcohol Depend. 8: 93-101, 1981.
28. LITTLE, P. J., COMPTON, D. R., JOHNSON, M. R., MELVIN, L. S. AND MARTIN, B. R : Pharmacology and stereoselectivity of structurally novel cannabinoids in mice. J. Pharmacol. Exp. Ther. 247: 1046-1051, 1988.
29. 8-tetrahydrocannabinol. Pharmacol. Biochem. Behav. 32: 661-666, 1989.
30. LOMAX, P. AND CAMPBELL, C.: Phenitrone and marihuana induced hypothermia. Experientia 27: 1191-1192, 1971.
31. 9-THC. Pharmacol. Biochem. Behav. 46: 295-301, 1993.
32. MARTIN, B. R., CHILDERS, S., HOWLETT, A., MECHOULAM, R. AND PERTWEE, R.: Cannabinoid receptors: Pharmacology, second messenger systems and endogenous ligands. In Problems of Drug Dependence 1993: Proceedings of the 55th Annual Scientific Meeting, NIDA Research Monograph Series 140, pp. 55-60, US Government Printing Office, Washington, DC, 1994.
33. MARTIN, B. R., COMPTON, D. R., LITTLE, P. J., MARTIN, T. J. AND BEARDSLEY, P. M.: Pharmacological evaluation of agonistic and antagonistic activity of cannabinoids. In Structure-Activity Relationships of Cannabinoids. pp. 108-122, US Government Printing Office, Washington, DC, 1987.
34. MATSUDA, L. A., LOLAIT, S. J., BROWNSTEIN, M. J., YOUNG, A. C. AND BONNER, T. I.: Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561-564, 1990.
35. MECHOULAM, R., HANUS, L., BEN-SHABAT, S., FRIDE, E. AND WEIDENFELD, J.: The anandamides, a family of endogenous cannabinoid ligands - Chemical and biological studies. Neuropschychopharmacology 10: 145S-145S, 1994.
36. PACHECO, M., CHILDERS, S. R., ARNOLD, R., CASIANO, F. AND WARD, S. J.: Amino-alkylindoles: Actions on specific G-protein-linked receptors, J. Pharmacol. Exp. Ther. 257: 170-183, 1991.
37. RINALDI-CARMONA, M., BARTH, F., HÉAULME, M., SHIRE, D., CALANDRA, B., CONGY, C., MARTINEZ, S., MARUANI, J., NÉLIAT, G., CAPUT, D., FERRARA, P., SOUBRIÉ, P., BRELIÈRE, J. C. AND LE FUR, G.: SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350: 240-244, 1994.
38. SPAULDING, T. H. AND DEWEY, W. L.: The effects of phenitrone, a reported hashish antagonist, on the overt behavior of cats. Res. Comm. Chem. Path. Pharmacol. 7: 347-352, 1974.
39. TALLARIDA, R. J. AND MURRAY, R. B.: Graded dose-response. In Manual of Pharmacologic Calculations, pp. 26-31, Springer-Verlag, New York, 1987.